Nuntius Therapeutics

Developer of DNA, RNA, and CRISPR therapies for rare diseases

placeLondon, England, United Kingdom calendar_todayFounded 2021 groups3 employees language nuntiustx.com

Registered entities

Social engagement

Social engagement: 2.4K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

23 Sep 2025
Product launch
Advanced Science
Coming soon